Schwann cell grafts show promise in Parkinson's disease

'Remarkable improvement' in 60 patients given the grafts, authors report

Grafting autologous Schwann cells to the substantia nigra appears to improve motor function in people with Parkinson's disease up to at least two years after the surgery, according to new findings.